Analgesics - Gabon

  • Gabon
  • In Gabon, the revenue generated in the Analgesics market in 2024 amounts to US$3.74m.
  • It is projected that the market will experience an annual growth rate of 4.63% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in the Analgesics market, reaching US$7,243.00m in 2024.
  • In terms of per capita figures, in Gabon, each person generates revenues of US$1.51 in 2024.
  • Despite the availability of OTC analgesics in Gabon, traditional remedies such as herbal medicines continue to be preferred by many locals.

Key regions: Brazil, Europe, Germany, Canada, United States

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics market in Gabon has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development.Customer preferences in Gabon have shifted towards a greater demand for analgesics. This can be attributed to several factors, including an aging population and an increase in chronic diseases. As the population ages, the prevalence of conditions such as arthritis and back pain has risen, leading to a greater need for pain relief medication. Additionally, the rise in chronic diseases such as diabetes and cardiovascular disease has also contributed to the increased demand for analgesics.Trends in the market have also played a role in the growth of the Analgesics market in Gabon. One notable trend is the increased availability of over-the-counter analgesics. Previously, analgesics were primarily available through prescription, but now they can be easily purchased without a prescription. This has made analgesics more accessible to the general population, further driving demand.Another trend in the market is the introduction of new and innovative analgesic products. Pharmaceutical companies are constantly developing new formulations and delivery methods for analgesics, such as patches and gels. These products offer convenience and targeted pain relief, making them popular among consumers.Local special circumstances in Gabon have also contributed to the growth of the Analgesics market. Gabon has a high prevalence of infectious diseases, such as malaria, which can cause fever and pain. As a result, analgesics are often used to manage symptoms associated with these diseases. Additionally, Gabon has a high rate of sports injuries, particularly in football, which also drives demand for analgesics.Underlying macroeconomic factors have also played a role in the development of the Analgesics market in Gabon. The country has experienced steady economic growth, leading to an increase in disposable income among the population. As a result, consumers have more purchasing power and are able to afford analgesics. Furthermore, the government has implemented policies to improve healthcare access and affordability, which has also contributed to the growth of the market.In conclusion, the Analgesics market in Gabon has been growing due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The increased demand for analgesics can be attributed to an aging population, an increase in chronic diseases, and the availability of over-the-counter products. The introduction of new and innovative analgesic products, the prevalence of infectious diseases and sports injuries, and the country's economic growth and healthcare policies have all contributed to the development of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)